Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscleinvasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette- Guérin (BCG): results of an international individual patient data survey (IPDS)
Re: Randomized Noninferiority Trial of Reduced High-Dose Volume versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004) R. A. Huddart, E. Hall, S. A. Hussain, P. Jenkins, C. Rawlings, J. Tremlett, M. Crundwell, F. A. Adab, D. Sheehan, I. Syndikus, C. Hendron, R. Lewis, R. Waters and N. D. James Institute of Cancer Research and Royal Marsden Hospitals, Sutton, United Kingdom Int J Radiat Oncol Biol Phys 2013; 87: 261e269.